Federal Register #2026-05906

This notice from the Justice Department's Antitrust Division provides an update on the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAPCONSORTIUM) under the National Cooperative Research and Production Act of 1993. - Government Buyer: - U.S. Department of Justice, Antitrust Division - Consortium Membership Changes: - New members include: - AGC Biologics - Anavatos Bio, Inc. - Cidara Therapeutics INC - Crossmhv, L.l.C - Defense Operations & Execution Solutions INC - Health Supply US LLC - Nanopass Technologies Ltd. - Ommio Health, INC - UI Pharmaceuticals - Axelyf, Inc. - BetteRx Compounding Inc. - Crossject SA - Lavik Consulting LLC - Nanotag Biotechnologies Gmbh - Quality Assured Artificial Intelligence LLC - Award Advisors - Beckman Research Institute of the City of Hope - Gemini Therapeutics - Lumacyte, INC - Modus Operandi - Ship Odyssey, Inc. - Synergistic INC - Occam Systems Incorporated - Renco Manufacturing Group INC - Revolution Biomanufacturing INC - Sagitta Biotech - Argentum Pharmaceuticals LLC - Culmen International, LLC - EXCITE PHARMA SERVICES, LLC - Johns Hopkins Center for Health Security - KNIGHT GREGORIAN, INC. - Kensington Street Consulting LLC - Method Made - Mriglobal - N! Biomachines Ltd. - Safi Biotherapeutics INC - Science Systems and Applications, Inc. - True Diagnostics, Inc. - Zeteo Biomedical LLC - Purpose and Scope: - Notice is administrative, documenting changes in consortium membership - No procurement of products or services is involved - Membership remains open and further updates will be provided - Notable Details: - Consortium focuses on collaborative research and manufacturing preparedness in the biopharmaceutical sector - No specific products, part numbers, or quantities are requested or awarded in this notice

This notice announces changes in membership for the Biopharmaceutical Manufacturing Preparedness Consortium under the National Cooperative Research and Production Act of 1993. The consortium includes various biopharmaceutical companies and research organizations collaborating to advance manufacturing preparedness in the biopharmaceutical sector. The notice details additions of new members and confirms that membership remains open, with plans to file further notifications of changes. The Department of Justice and the Antitrust Division oversee this cooperative research initiative.